Chicago, IL · Founded 2020 · Privately Held (backing)
Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. Grove Biopharma is based in Chicago, IL and was founded in 2020. Its last reported valuation was $64 million in Apr 2025. It has raised $44 million.
Last reported valuation
$64.0M
Oct 2026
Priced at
—
Total raised
$44.0M
Last round
—
Cap table — not yet on record
Grove Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Grove Biopharma with a free account
·The complete investor list: 13 names
·Watch Grove Biopharma: the Monday email on marks, rounds and moves
